Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Change in Inventory (2020 - 2025)

Bioventus' Change in Inventory history spans 6 years, with the latest figure at -$13.0 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 333.2% year-over-year to -$13.0 million; the TTM value through Dec 2025 reached -$8.6 million, down 152.14%, while the annual FY2025 figure was -$8.6 million, 152.14% down from the prior year.
  • Change in Inventory reached -$13.0 million in Q4 2025 per BVS's latest filing, down from -$291000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $10.0 million in Q4 2022 to a low of -$13.0 million in Q4 2025.
  • Average Change in Inventory over 5 years is $1.5 million, with a median of $2.7 million recorded in 2024.
  • Peak YoY movement for Change in Inventory: surged 1723.93% in 2023, then plummeted 333.2% in 2025.
  • A 5-year view of Change in Inventory shows it stood at -$1.7 million in 2021, then soared by 692.59% to $10.0 million in 2022, then crashed by 181.34% to -$8.1 million in 2023, then surged by 168.38% to $5.6 million in 2024, then tumbled by 333.2% to -$13.0 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Change in Inventory are -$13.0 million (Q4 2025), -$291000.0 (Q3 2025), and $2.8 million (Q2 2025).